article · Evidence-based Complementary and Alternative Medicine
Prostatic complications frequently affect individuals with diabetes. An investigation evaluated the therapeutic potential of three active ginger ingredients, specifically zingerone, geraniol, and 6-gingerol, in male rats with chemically induced diabetes over an eight-week treatment regimen. While none of the compounds reversed high blood glucose, body weight loss, reduced testosterone, or elevated inflammatory markers, they induced notable structural improvements within the ventral prostate. Geraniol and 6-gingerol reduced oxidative stress by lowering prostate malondialdehyde and boosting the ratio of reduced to oxidised glutathione. Furthermore, zingerone and geraniol lessened tissue fibrosis by suppressing transforming growth factor beta 1 and collagen IV levels. Together, these specific components can alleviate diabetic prostatic complications by directly targeting oxidative damage and structural scarring.
Prostate complications are a frequent and challenging consequence of diabetes. Identifying that specific constituents of ginger can protect prostate tissue against oxidative stress and fibrous scarring provides valuable biological insight into preserving organ function, offering an alternative avenue to manage secondary diabetic issues independently of blood glucose regulation.
This work represents early-stage research in an animal model, identifying potential active molecules for treating diabetic prostate complications. It could interest pharmaceutical or nutraceutical developers seeking functional ingredients or therapeutic leads. However, the findings remain at a preclinical stage, meaning human clinical testing and delivery formulation would be required before commercial application is viable.
AI-generated from the published abstract. Always read the original work before citing.
Prostatic complications are common in patients with diabetes. This study investigated the effect of different ginger ingredients: zingerone, geraniol, and 6-gingerol on the prostate in diabetic rats. Diabetes was induced in Wistar rats by streptozotocin intraperitoneal injection (50 mg/kg), and the rats were left for 10 weeks to develop prostatic complications. In diabetic treated groups, rats received daily oral zingerone, geraniol, and 6-gingerol in doses of 20, 200, and 75 mg/kg, respectively, in the last 8 weeks. Treatment with the compounds caused changes in the ventral prostate of diabetic animals as indicated by the columnar ductal epithelium and dense secretions. There was an amelioration of oxidative stress as evidenced by the lowering of prostate malondialdehyde and elevating prostate oxidized to reduced glutathione (GSH/GSSG) ratios by geraniol and 6-gingerol. None of the three ginger ingredients affected the hyperglycemia, reduction in body weight gain, and testosterone deficiency seen in diabetic animals. Interleukin-1<i>β</i> and interleukin-6 levels remained unchanged. However, zingerone and geraniol ameliorated the fibrosis in diabetic prostate through suppressing the elevated prostate transforming growth factor beta 1 (TGF<i>β</i>1) and collagen IV. Therefore, ginger ingredients could be beneficial in alleviating diabetic prostatic complications through suppressing oxidative stress and tissue fibrosis.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1155/2017/6090269
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
